A nanoparticle formulation based on curcumin and lipoic acid crosslinked to human serum albumin has been demonstrated to intensify the in vitro antitumor effects of Doxorubicin against H295R adrenocortical tumor cells and demonstrated the effective and fast uptake of the nanoparticle. The gene discussed is ALB; the disease is adrenal cortex neoplasm.